Informe Médico: Evolución y Diagnóstico
Informe Médico: Evolución y Diagnóstico
The pathologies ruled out based on the uroTAC and urinalysis include nephrolithiasis and urolithiasis, as there were no kidney stones detected in the UroTAC, and the urinalysis was not pathological with no signs of hematuria or infection. This directs the focus towards further investigation of the pelvic mass and potential causes of abdominal pain .
The primary findings from the uroTAC include the presence of a pelvic mass adjacent to the uterus, and no indications of nephrolithiasis or urolithiasis. There is also a hernia umbilical and an indirect inguinal hernia on the right side. These findings inform the clinical plan by indicating the need for further imaging to characterize the pelvic mass, as well as consideration for potential surgical evaluation of the hernias .
The recommended diagnostic tests for further evaluation of the pelvic mass adjacent to the uterus include a simple and contrast-enhanced CT scan of the abdomen and a transvaginal ultrasound. The rationale for these tests is to provide a detailed assessment of the pelvic mass that was observed on the initial UroTAC, as these methods allow for better visualization of soft tissue structures and can differentiate between various types of masses and potential pathologies .
The hemogram shows a mild leukocytosis with neutrophilia, which suggests an ongoing inflammatory process, possibly due to the pelvic mass or another source of inflammation. The absence of anemia and the normal PCR levels help rule out some potential acute conditions like significant infections. These results, combined with imaging findings, suggest that the primary concern may relate to the pelvic mass, and guide the need for further imaging rather than immediate invasive intervention .
The patient's medical history and surgical background, which include cesarean sections and a tubectomy, are important for understanding potential causes of her abdominal symptoms, such as the possibility of adhesions or hernias resulting from previous surgeries. This background aids clinicians in narrowing down differential diagnoses and informs the management plan concerning potential surgical interventions or the need for advanced imaging techniques .
The absence of significant past medical history implies that the current abdominal pain is less likely related to chronic conditions, thereby increasing the focus on acute etiologies such as the identified pelvic mass. This influences the diagnostic process by streamlining the investigatory focus towards ruling out acute pathologies rather than managing chronic illnesses, ultimately impacting the urgency and type of diagnostic tests and interventions considered .
The incidental findings of umbilical and right inguinal hernias on imaging necessitate consideration for surgical evaluation due to their potential to cause complications if they enlarge or become incarcerated. While these hernias may not be the direct cause of the patient's current symptoms, they must be monitored and possibly addressed to prevent future complications, which adds complexity to the overall treatment plan .
The patient's immunization status, specifically having received four doses of the COVID-19 vaccine, reduces the likelihood of her current symptoms being related to a COVID-19 infection, allowing clinicians to focus on non-infectious causes of her abdominal pain .
Key clinical signs critical for assessing the severity of the patient's abdominal symptoms include the presence of tenderness in the hypogastric region and left iliac fossa, lack of peritoneal irritation signs such as rebound tenderness, and hemodynamic stability. These signs suggest a localized abdominal process rather than a generalized peritoneal emergency, allowing for a more measured approach in further evaluation and management .
A transvaginal ultrasound is suggested as a complementary test for the pelvic mass because it provides excellent resolution of the pelvic organs, is minimally invasive, and can offer detailed information about the nature, size, and content of the mass, such as detecting cystic versus solid structures. This non-invasive test helps to assess whether the mass is potentially benign or requires further intervention .